CoChat

GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment Study

Open access
Margulies, Kenneth B., Anstrom, Kevin J., Hernandez, Adrian F., Redfield, Margaret M., Shah, Monica R., Braunwald, Eugene, Cappola, Thomas P. · 2014 · Circulation: Heart Failure
Cited by 46

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

H eart failure (HF) is a leading cause of mortality and mor- bidity in the industrialized world and imposes a substantial burden on public health.In the United States, HF is the primary cause of death for more than 60 000 people annually and a contributing factor in over 282 000 cases. 1 Despite guidelinerecommended therapy for patients with HF and reduced ejection fraction, 1 the 1-year mortality in patients with New York Heart Association (NYHA) functional class III to IV HF on maximal medical therapy is 35% to 40%. 2 Based on recent estimates, approximately 5.1 million adult Americans have HF, and projections show that by the year 2030 the prevalence of HF in the United States will increase by 25%. 2 By any metric, HF imposes a major public health and financial burden on society.The lack of new disease-modifying pharmacological therapy for HF over the past 2 decades further amplifies these concerns.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.114.000346

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 46

Metadata

Authors
Margulies, K. B., Anstrom, K. J., Hernandez, A. F., Redfield, M. M., Shah, M. R., Braunwald, E., & Cappola, T. P.
Venue
Circulation: Heart Failure
Published
2014-07
Volume
7
Issue
4
Pages
673-679
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2129126699
Cited by
46
References
7
FWCI
4.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment Study. https://app.cochat.ai/papers/10.1161/circheartfailure.114.000346
The paper
Margulies, K. B., Anstrom, K. J., Hernandez, A. F., Redfield, M. M., Shah, M. R., Braunwald, E., & Cappola, T. P. (2014). GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment Study. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.114.000346

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.